Trintellix vs. Lexapro: Differences, Side Effects, and How to Choose
Author:
Blossom Editorial
May 7, 2026
Trintellix (vortioxetine) and Lexapro (escitalopram) are both commonly prescribed antidepressants, but they work in different ways and may be better suited to different people.
Lexapro is a selective serotonin reuptake inhibitor (SSRI) with a long track record for treating both depression and anxiety. Trintellix is a newer medication with a more complex mechanism that may offer added benefits for people experiencing cognitive symptoms along with depression. The cognitive symptoms include concentration problems, brain fog, and memory difficulties.
If you're deciding between these medications or considering a switch, this guide explains how they compare in effectiveness, side effects, dosing, and who may benefit most from each.
Key Takeaways
Lexapro (escitalopram) is a well-studied SSRI approved for both depression and generalized anxiety disorder. It’s available as a low-cost generic.
Trintellix (vortioxetine) works on multiple serotonin receptors and may help with cognitive symptoms like concentration and memory.
Side effects differ: Sexual side effects tend to be meaningfully lower with Trintellix compared to SSRIs, while cost is typically much higher compared to generic escitalopram. As of early 2026, there is no generic version of Trintellix in the market.
How Lexaro and Trintellix Work
Lexapro is an SSRI antidepressant that works by blocking serotonin reabsorption and increasing serotonin levels in the brain. This helps regulate mood and anxiety. Compared to other SSRIs, it is highly selective towards the serotonin transporter receptor and doesn’t have affinity for neurotransmitters such as dopamine or norepinephrine.
Trintellix is a serotonin modulator and stimulator (SMS). In addition to blocking serotonin reabsorption, it interacts with other serotonergic receptors, such as 5-HT1A, 5-HT1B, 5-HT3, 5-HT1D, and 5-HT7. According to FDA prescribing information for Trintellix, this may influence mood, cognition, and anxiety in more complex ways. Researchers are still studying how these effects translate clinically.
FDA-Approved Uses
Lexapro and Trintellix are FDA-approved to treat different conditions.
Lexapro is approved for:
Major depressive disorder (MDD) in adults and adolescents 12 and older
Generalized anxiety disorder (GAD) in adults
It is also commonly prescribed off-label for other anxiety disorders, including panic disorder, social anxiety, and OCD.
Trintellix is approved for MDD in adults only.
While some studies suggest Trintellix may help with anxiety symptoms, it is currently not FDA-approved for anxiety disorders. However, providers sometimes use it off-label for some patients with severe anxiety. If anxiety is a primary concern, Lexapro may be a more suitable starting point.
Dosing
Both medications are typically taken once daily with or without food and often start at similar doses. From there, the doses are adjusted based on your response and tolerability.
Lexapro (Escitalopram) | Trintellix (Vortioxetine) | |
Starting dose | 10 mg once daily | 10 mg once daily |
Maintenance range | 10–20 mg/day | 10–20 mg/day |
Maximum dose | 20 mg/day | 20 mg/day |
Adolescent dosing (MDD) | 10 mg/day (12+) | Not approved |
Dosing in people with liver impairment | Use with caution | Use with caution |
Dosing frequency | Once daily | Once daily |
For Trintellix, a typical dose of 10 mg is often effective for many people, with 20 mg providing additional benefit for some. However, doses below 10 mg are generally not considered therapeutic for most people.
Effectiveness for Depression
Both medications are considered effective for major depression.
A large-scale network meta-analysis in The Lancet found escitalopram (Lexapro) to be among the more effective and well-tolerated antidepressants. Vortioxetine (Trintellix) has also shown effectiveness compared to placebo in clinical trials, though it was introduced more recently and has a smaller long-term evidence base.
There is no strong evidence that one is consistently more effective than the other for overall depression. The choice often depends on specific symptoms and side effects.
Cognitive Effects: A Key Difference
Depression can affect more than mood - it often impacts:
Concentration
Memory
Processing speed
Decision-making
Brain fog
These symptoms can sometimes persist even after mood improves, and affect daily functioning and quality of life.
A study on vortioxetine (Trintellix) found that it may improve cognitive function, including processing speed, memory, and executive function, compared to placebo in adults with MDD. These benefits may occur partly independent of mood improvement.
Escitalopram (Lexapro) has not been specifically shown to provide these targeted cognitive effects. However, such cognitive symptoms often improve as depression improves.
Side Effect Comparison: Trintellix vs. Lexapro
Both medications are generally well-tolerated, but their side effect profiles differ in meaningful ways.
Side Effect | Lexapro | Trintellix |
Nausea | Mild, common early (in the first two weeks) | Common, dose-dependent |
Sexual side effects | Common | Less common |
Weight gain | Minimal | |
Insomnia/sedation | Common | Less common |
Headache | Possible | Possible |
Discontinuation syndrome | Possible if stopped abruptly | Less common |
Sexual side effects are a common reason people discontinue SSRIs. A study in the Journal of Sexual Medicine suggested that vortioxetine (Trintellix) had a lesser impact on sexual dysfunction than escitalopram (Lexapro) in patients with MDD.
For some people, this difference alone may influence medication choice.
Drug Interactions
Both medications increase serotonin activity. This means that they both carry a risk of serotonin syndrome when combined with other serotonin-affecting drugs (such as MAOIs, triptans, tramadol, or other antidepressants).
It is recommended that neither medication be started within 14 days of stopping an MAOI. Both medications can increase the risk of bleeding when co-administered with NSAIDs, aspirin, warfarin, or other anticoagulants.
Additional considerations for Trintellix interactions:
Strong CYP2D6 inhibitors (like fluoxetine) can increase its levels
Strong CYP enzyme inducers (like rifampin) can lower its levels and potentially reduce its effectiveness
Additional considerations for Lexapro interactions:
Generally, Lexapro has fewer significant enzyme-based interactions, which may make it easier to manage alongside other medications.
Cost: A Practical Consideration
Cost is a real factor that is often overlooked in treatment decisions. For many people, affordability plays a major role in choosing a medication.
Lexapro is available as escitalopram, a low-cost generic available at most pharmacies, often for under $60 per month without insurance or coupons.
Trintellix remains a brand-name medication as of early 2026, with a significantly higher list price that can reach hundreds of dollars per month without insurance coverage.
Insurance coverage varies, and savings programs may be available for Trintellix. If cost is a barrier, it’s best to talk to your healthcare provider and pharmacist. They can help navigate coverage options.
Which Medication is Right for You?
In general, Lexapro may be a better fit if:
You have depression with significant anxiety — GAD, panic disorder, or social anxiety
Cost is a concern
You prefer a medication with a long and well-documented track record
You are under 18 (Trintellix is not approved for adolescents)
Trintellix may be worth considering if:
Cognitive symptoms — concentration, memory, mental fog — are particularly disruptive to your daily life
Sexual side effects from a previous SSRI were a significant problem
You haven’t responded well to other antidepressants
Your insurance covers Trintellix, and cost is not a barrier
Ready to Take the Next Step?
If you’re considering starting or switching antidepressants, working with a qualified provider can make the process safer and more effective. Blossom Health connects you with board-certified psychiatric providers — covered by insurance. Virtual appointments available within days. Book your first appointment now to get started.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
FDA Prescribing Information. (January, 2017). Lexapro (escitalopram). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021323s047lbl.pdf
FDA Prescribing Information. (January, 2021). Trintellix (vortioxetine). https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204447s021s022lbl.pdf
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (London, England), 391(10128), 1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7
Alvarez, E., Perez, V., & Artigas, F. (2014). Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder. Neuropsychiatric disease and treatment, 10, 1297–1307. https://doi.org/10.2147/NDT.S41387
Yee, A., Ng, C. G., & Seng, L. H. (2018). Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study. Current drug targets, 19(12), 1412–1423. https://doi.org/10.2174/1389450118666171117131151
McIntyre, R. S., Florea, I., Tonnoir, B., Loft, H., Lam, R. W., & Christensen, M. C. (2017). Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder. The Journal of clinical psychiatry, 78(1), 115–121. https://doi.org/10.4088/JCP.16m10744
Jacobsen, P. L., Mahableshwarkar, A. R., Chen, Y., Chrones, L., & Clayton, A. H. (2015). Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction. The journal of sexual medicine, 12(10), 2036–2048. https://doi.org/10.1111/jsm.12980
NIMH. (December, 2024). Depression. https://www.nimh.nih.gov/health/topics/depression
NCBI. (December 01, 2025). Vortioxetine (StatPearls). https://www.ncbi.nlm.nih.gov/books/NBK537042/
Cleveland Clinic – Escitalopram (Lexapro). https://my.clevelandclinic.org/health/drugs/18917-escitalopram-tablets
